{"hands_on_practices": [{"introduction": "The remarkable ability of HIV to evolve and evade the immune system and antiviral drugs stems from its high mutation rate. This first practice invites you to perform a fundamental calculation that quantifies this characteristic [@problem_id:2233858]. By using the known error rate of the reverse transcriptase enzyme, you will estimate the average number of mutations introduced into the viral genome during a single round of replication, providing a tangible starting point for understanding HIV's genetic diversity.", "problem": "The Human Immunodeficiency Virus (HIV) is a retrovirus renowned for its high genetic variability, a characteristic that poses significant challenges for vaccine development and antiviral therapy. This high mutation rate is primarily attributed to the lack of a proofreading mechanism in its reverse transcriptase enzyme, which transcribes the viral RNA genome into DNA. Consider a simplified model of HIV-1 replication. The single-stranded RNA genome of HIV-1 has a length of approximately 9749 nucleotides. The average error rate for the reverse transcriptase enzyme is estimated to be $3.0 \\times 10^{-5}$ substitutions per nucleotide base incorporated.\n\nBased on this information, calculate the expected number of new point mutations that will be introduced into the viral genome during a single cycle of reverse transcription, where the entire RNA genome is copied into a DNA strand.\n\nRound your final answer to three significant figures.", "solution": "We model errors during reverse transcription as independent Bernoulli trials at each nucleotide position with probability $p$ of a substitution error per incorporated base. For a genome of length $L$, the expected number of point mutations introduced in one full copy is given by the linearity of expectation for a binomial process:\n$$\nE = L \\, p.\n$$\nSubstituting the given values $L = 9749$ nucleotides and $p = 3.0 \\times 10^{-5}$ substitutions per nucleotide,\n$$\nE = 9749 \\times 3.0 \\times 10^{-5} = 0.29247.\n$$\nRounding to three significant figures yields $0.292$.", "answer": "$$\\boxed{0.292}$$", "id": "2233858"}, {"introduction": "High mutation rates naturally lead to the evolution of drug resistance, a major challenge in HIV therapy. This exercise explores a subtle but clinically important resistance mechanism where mutations occur not in the drug's target enzyme, but in its substrate [@problem_id:2071904]. You will apply principles of enzyme kinetics to analyze how a change in the Gag polyprotein can allow the virus to replicate more effectively in the presence of a protease inhibitor, demonstrating the complex interplay between viral evolution and pharmacology.", "problem": "A patient infected with the Human Immunodeficiency Virus (HIV) is undergoing antiretroviral therapy that includes a potent protease inhibitor. After an initial period of viral suppression, the patient's viral load rebounds, indicating the emergence of a drug-resistant strain. Subsequent genetic sequencing reveals a surprising result: the gene encoding the viral protease is identical to the wild-type (WT) sequence, meaning the enzyme itself is unchanged. However, a single point mutation is found in the viral `gag` gene, altering an amino acid at a primary cleavage site within the Gag polyprotein substrate.\n\nTo understand how this substrate mutation, rather than an enzyme mutation, can confer resistance, a kinetic analysis is performed. The wild-type protease is used to cleave both the wild-type Gag substrate (WT) and the mutated Gag substrate (Mut). The therapy maintains a steady-state intracellular concentration of the protease inhibitor, $[I]$. The inhibitor acts as a competitive inhibitor. Crucially, due to subtle conformational effects, the inhibitor's binding affinity for the protease depends on which substrate is being processed.\n\nYou are given the following kinetic parameters and in vivo concentrations:\n-   **Wild-type (WT) reaction:**\n    -   Catalytic constant, $k_{cat,WT} = 25.0 \\text{ s}^{-1}$\n    -   Michaelis constant, $K_{m,WT} = 50.0~\\mu\\text{M}$\n    -   Inhibition constant, $K_{i,WT} = 2.00 \\text{ nM}$\n-   **Mutated (Mut) reaction:**\n    -   Catalytic constant, $k_{cat,Mut} = 10.0 \\text{ s}^{-1}$\n    -   Michaelis constant, $K_{m,Mut} = 500.0~\\mu\\text{M}$\n    -   Inhibition constant, $K_{i,Mut} = 80.0 \\text{ nM}$\n-   **In vivo concentrations:**\n    -   Gag polyprotein substrate concentration, $[S] = 75.0~\\mu\\text{M}$\n    -   Protease inhibitor concentration, $[I] = 198.0 \\text{ nM}$\n\nCalculate the relative processing rate of the mutant Gag polyprotein compared to the wild-type Gag polyprotein under these therapeutic conditions. This is given by the ratio of the reaction velocities, $v_{Mut} / v_{WT}$. Express your answer as a dimensionless number rounded to three significant figures.", "solution": "For a competitive inhibitor, the Michaelis–Menten rate law is\n$$\nv=\\frac{k_{cat}[E]_{T}[S]}{\\alpha K_{m}+[S]},\\quad \\alpha=1+\\frac{[I]}{K_{i}}.\n$$\nFor the wild-type (WT) and mutant (Mut) substrates processed by the same protease, the ratio of velocities under the same enzyme and substrate concentrations is\n$$\n\\frac{v_{Mut}}{v_{WT}}=\\frac{k_{cat,Mut}}{k_{cat,WT}}\\cdot\\frac{\\alpha_{WT}K_{m,WT}+[S]}{\\alpha_{Mut}K_{m,Mut}+[S]},\n$$\nbecause the common factor $[E]_{T}[S]$ cancels.\n\nCompute the inhibitor factors for each substrate:\n$$\n\\alpha_{WT}=1+\\frac{[I]}{K_{i,WT}}=1+\\frac{198}{2.00}=100,\n\\qquad\n\\alpha_{Mut}=1+\\frac{[I]}{K_{i,Mut}}=1+\\frac{198}{80.0}=3.475.\n$$\nInsert the given kinetic parameters and $[S]=75.0$:\n$$\n\\frac{v_{Mut}}{v_{WT}}\n=\\left(\\frac{10.0}{25.0}\\right)\\cdot\\frac{100\\cdot 50.0+75.0}{3.475\\cdot 500.0+75.0}\n=0.4\\cdot\\frac{5000+75}{1737.5+75}\n=0.4\\cdot\\frac{5075}{1812.5}.\n$$\nEvaluate the ratio:\n$$\n\\frac{5075}{1812.5}=2.8 \\quad \\Rightarrow \\quad \\frac{v_{Mut}}{v_{WT}}=0.4\\times 2.8=1.12.\n$$\nThus, the mutant Gag polyprotein is processed faster than the wild-type under these inhibitory conditions due to the much weaker inhibition in the mutant context.", "answer": "$$\\boxed{1.12}$$", "id": "2071904"}, {"introduction": "The ultimate consequence of an untreated HIV infection is the depletion of CD4 T-cells, leading to AIDS. This final practice challenges you to model this pathogenic process by linking a key virological parameter—the viral load set point—to the rate of immune decline [@problem_id:4652119]. By deriving and analyzing a mathematical model for the time to AIDS, you will gain insight into the quantitative factors that govern disease progression and learn how sensitivity analysis can reveal critical drivers of pathogenesis.", "problem": "A chronic Human Immunodeficiency Virus (HIV) infection typically reaches a relatively stable “set point” viral load after the acute phase, during which the Acquired Immunodeficiency Syndrome (AIDS) risk emerges predominantly through a long-term decline of CD4 T lymphocytes. Empirical observations and mechanistic reasoning from mass-balance of cell production and loss during the set-point phase indicate that the net CD4 decline rate increases with viral load and saturates as a function of the set point. Consider the following scientifically plausible model for the chronic phase: the per-month decline in CD4 cell concentration is the product of a maximal per-month decline parameter and a saturating function of the viral load set point. Specifically, let the CD4 concentration be denoted by $C(t)$ (cells per microliter), the initial CD4 concentration at the start of chronic phase by $C_{0}$ (cells per microliter), the AIDS diagnostic threshold by $C_{A}$ (cells per microliter), the viral load set point by $V_{s}$ (copies per milliliter), the half-saturation constant by $K$ (copies per milliliter), and the maximal per-month decline parameter by $d$ (cells per microliter per month). Assume the chronic-phase decline is approximately linear with time and satisfies\n$$\n\\frac{dC}{dt} \\approx -\\,d\\,\\frac{V_{s}}{K+V_{s}} \\quad \\text{(constant in time during set point)},\n$$\nwith $C(t)$ decreasing from $C_{0}$. AIDS is diagnosed when $C(t)$ first reaches $C_{A}$.\n\n1. Starting from the above assumptions and the definition of the AIDS threshold, derive an analytic expression $T(C_{0},V_{s},d)$ for the expected time to AIDS (in months). Your derivation should make clear the steps from the model to the expression for $T$ and must not rely on any unproven shortcut formulas.\n\n2. Compute the parameter sensitivities $\\frac{\\partial T}{\\partial C_{0}}$, $\\frac{\\partial T}{\\partial V_{s}}$, and $\\frac{\\partial T}{\\partial d}$.\n\n3. Evaluate $T$, $\\frac{\\partial T}{\\partial C_{0}}$, $\\frac{\\partial T}{\\partial V_{s}}$, and $\\frac{\\partial T}{\\partial d}$ numerically for the following values grounded in clinical plausibility: $C_{0} = 800$ cells per microliter, $C_{A} = 200$ cells per microliter, $V_{s} = 1.0 \\times 10^{4}$ copies per milliliter, $K = 5.0 \\times 10^{4}$ copies per milliliter, and $d = 36$ cells per microliter per month. Round each numerical quantity to four significant figures.\n\nExpress the expected time to AIDS $T$ in months. Express $\\frac{\\partial T}{\\partial C_{0}}$ in months per (cells per microliter), $\\frac{\\partial T}{\\partial V_{s}}$ in months per (copies per milliliter), and $\\frac{\\partial T}{\\partial d}$ in months per (cells per microliter per month). Return your final answer as a row matrix containing, in this order, $T$, $\\frac{\\partial T}{\\partial C_{0}}$, $\\frac{\\partial T}{\\partial V_{s}}$, and $\\frac{\\partial T}{\\partial d}$.", "solution": "The problem is first validated to ensure it is scientifically grounded, well-posed, and objective before a solution is attempted.\n\n### Step 1: Extract Givens\n-   **Variables and Functions:**\n    -   $C(t)$: CD4 cell concentration at time $t$ (cells per microliter).\n    -   $t$: time (months).\n-   **Parameters and Constants:**\n    -   $C_{0}$: Initial CD4 concentration at $t=0$ (cells per microliter).\n    -   $C_{A}$: AIDS diagnostic threshold for CD4 concentration (cells per microliter).\n    -   $V_{s}$: Viral load set point (copies per milliliter).\n    -   $K$: Half-saturation constant (copies per milliliter).\n    -   $d$: Maximal per-month decline parameter (cells per microliter per month).\n-   **Governing Equation:**\n    $$\n    \\frac{dC}{dt} \\approx -\\,d\\,\\frac{V_{s}}{K+V_{s}}\n    $$\n-   **Initial Condition:** $C(0) = C_{0}$.\n-   **Terminal Condition:** AIDS is diagnosed at time $T$ when $C(T) = C_{A}$.\n-   **Numerical Values for Evaluation:**\n    -   $C_{0} = 800$ cells/µL\n    -   $C_{A} = 200$ cells/µL\n    -   $V_{s} = 1.0 \\times 10^{4}$ copies/mL\n    -   $K = 5.0 \\times 10^{4}$ copies/mL\n    -   $d = 36$ cells/µL/month\n\n### Step 2: Validate Using Extracted Givens\n-   **Scientifically Grounded:** The problem uses a simplified, yet mechanistically plausible, mathematical model for CD4 T-cell decline in chronic HIV infection. The use of a saturating function (Michaelis-Menten form) to describe the effect of viral load on the decline rate is a standard approach in biological modeling. The parameter values are stated to be clinically plausible. The model is a valid representation for educational and analytical purposes.\n-   **Well-Posed:** The problem is a well-defined initial value problem for a first-order ordinary differential equation with a constant rate term. It asks for a derivation, sensitivity analysis, and numerical evaluation, all of which are standard and well-defined mathematical tasks. A unique, stable, and meaningful solution exists.\n-   **Objective:** The problem is stated in precise, quantitative, and unbiased language. All terms are defined, and the goals are unambiguous.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid** as it is scientifically grounded, well-posed, and objective. There are no contradictions, missing information, or logical flaws. The solution process will now proceed.\n\n### Part 1: Derivation of the Time to AIDS, $T$\n\nThe rate of change of the CD4 cell concentration, $C(t)$, is given by the differential equation:\n$$\n\\frac{dC}{dt} = -d \\frac{V_{s}}{K+V_{s}}\n$$\nThe right-hand side of the equation is a constant with respect to time $t$, as $d$, $V_{s}$, and $K$ are parameters that are constant during the chronic set-point phase. Let this constant rate of decline be denoted by $R$:\n$$\nR = d \\frac{V_{s}}{K+V_{s}}\n$$\nSo the differential equation simplifies to:\n$$\n\\frac{dC}{dt} = -R\n$$\nThis is a simple first-order ordinary differential equation. We can solve it by direct integration with respect to time $t$. We integrate from the initial time $t=0$ to a general time $t$, and correspondingly from the initial concentration $C(0)=C_{0}$ to the concentration $C(t)$:\n$$\n\\int_{C(0)}^{C(t)} dC' = \\int_{0}^{t} (-R) dt'\n$$\n$$\nC(t) - C(0) = -R(t-0)\n$$\nSubstituting $C(0) = C_{0}$, we get the expression for $C(t)$:\n$$\nC(t) = C_{0} - Rt\n$$\nSubstituting the expression for $R$:\n$$\nC(t) = C_{0} - \\left(d \\frac{V_{s}}{K+V_{s}}\\right) t\n$$\nAIDS is diagnosed at the time $T$ when the CD4 concentration reaches the threshold $C_{A}$. Therefore, we set $t=T$ and $C(T)=C_{A}$:\n$$\nC_{A} = C_{0} - \\left(d \\frac{V_{s}}{K+V_{s}}\\right) T\n$$\nNow, we solve this algebraic equation for $T$.\n$$\n\\left(d \\frac{V_{s}}{K+V_{s}}\\right) T = C_{0} - C_{A}\n$$\n$$\nT = \\frac{C_{0} - C_{A}}{d \\frac{V_{s}}{K+V_{s}}}\n$$\nRearranging the expression gives the final analytic form for the time to AIDS, $T$, as a function of $C_{0}$, $V_{s}$, and $d$:\n$$\nT(C_{0},V_{s},d) = \\frac{(C_{0} - C_{A})(K+V_{s})}{d V_{s}}\n$$\n\n### Part 2: Computation of Parameter Sensitivities\n\nWe compute the partial derivatives of $T$ with respect to $C_{0}$, $V_{s}$, and $d$.\n\n**Sensitivity with respect to $C_{0}$:**\n$$\n\\frac{\\partial T}{\\partial C_{0}} = \\frac{\\partial}{\\partial C_{0}} \\left[ \\frac{(C_{0} - C_{A})(K+V_{s})}{d V_{s}} \\right]\n$$\nTreating all other parameters as constants, we have:\n$$\n\\frac{\\partial T}{\\partial C_{0}} = \\frac{K+V_{s}}{d V_{s}} \\frac{\\partial}{\\partial C_{0}}(C_{0} - C_{A}) = \\frac{K+V_{s}}{d V_{s}} (1) = \\frac{K+V_{s}}{d V_{s}}\n$$\n\n**Sensitivity with respect to $V_{s}$:**\nTo simplify the differentiation, we can rewrite $T$ as:\n$$\nT = \\frac{C_{0} - C_{A}}{d} \\left( \\frac{K+V_{s}}{V_{s}} \\right) = \\frac{C_{0} - C_{A}}{d} \\left( \\frac{K}{V_{s}} + 1 \\right) = \\frac{C_{0} - C_{A}}{d} (K V_{s}^{-1} + 1)\n$$\nNow we differentiate with respect to $V_{s}$:\n$$\n\\frac{\\partial T}{\\partial V_{s}} = \\frac{C_{0} - C_{A}}{d} \\frac{\\partial}{\\partial V_{s}} (K V_{s}^{-1} + 1) = \\frac{C_{0} - C_{A}}{d} (K(-1)V_{s}^{-2})\n$$\n$$\n\\frac{\\partial T}{\\partial V_{s}} = -\\frac{(C_{0} - C_{A})K}{d V_{s}^{2}}\n$$\n\n**Sensitivity with respect to $d$:**\n$$\n\\frac{\\partial T}{\\partial d} = \\frac{\\partial}{\\partial d} \\left[ \\frac{(C_{0} - C_{A})(K+V_{s})}{d V_{s}} \\right]\n$$\nWe can treat the term $\\frac{(C_{0} - C_{A})(K+V_{s})}{V_{s}}$ as a constant factor and rewrite $T$ as $T = \\frac{1}{d} \\left( \\frac{(C_{0} - C_{A})(K+V_{s})}{V_{s}} \\right)$. Differentiating with respect to $d$ gives:\n$$\n\\frac{\\partial T}{\\partial d} = -\\frac{1}{d^{2}} \\left( \\frac{(C_{0} - C_{A})(K+V_{s})}{V_{s}} \\right)\n$$\n$$\n\\frac{\\partial T}{\\partial d} = -\\frac{(C_{0} - C_{A})(K+V_{s})}{d^{2} V_{s}}\n$$\nThis can also be expressed as $\\frac{\\partial T}{\\partial d} = -\\frac{T}{d}$.\n\n### Part 3: Numerical Evaluation\n\nWe substitute the given numerical values into the derived expressions.\n-   $C_{0} = 800$\n-   $C_{A} = 200$\n-   $V_{s} = 1.0 \\times 10^{4} = 10000$\n-   $K = 5.0 \\times 10^{4} = 50000$\n-   $d = 36$\n\n**Evaluation of $T$:**\n$$\nT = \\frac{(800 - 200)(50000+10000)}{36 \\times 10000} = \\frac{600 \\times 60000}{360000} = \\frac{36 \\times 10^{6}}{3.6 \\times 10^{5}} = 100\n$$\nTo four significant figures, $T = 100.0$ months.\n\n**Evaluation of $\\frac{\\partial T}{\\partial C_{0}}$:**\n$$\n\\frac{\\partial T}{\\partial C_{0}} = \\frac{K+V_{s}}{d V_{s}} = \\frac{50000+10000}{36 \\times 10000} = \\frac{60000}{360000} = \\frac{1}{6} \\approx 0.166666...\n$$\nTo four significant figures, $\\frac{\\partial T}{\\partial C_{0}} = 0.1667$ months/(cell/µL).\n\n**Evaluation of $\\frac{\\partial T}{\\partial V_{s}}$:**\n$$\n\\frac{\\partial T}{\\partial V_{s}} = -\\frac{(C_{0} - C_{A})K}{d V_{s}^{2}} = -\\frac{(800 - 200)(50000)}{36 \\times (10000)^{2}} = -\\frac{600 \\times 50000}{36 \\times 10^{8}}\n$$\n$$\n\\frac{\\partial T}{\\partial V_{s}} = -\\frac{30 \\times 10^{6}}{36 \\times 10^{8}} = -\\frac{30}{36} \\times 10^{-2} = -\\frac{5}{6} \\times 10^{-2} \\approx -0.833333... \\times 10^{-2} = -0.00833333...\n$$\nTo four significant figures, $\\frac{\\partial T}{\\partial V_{s}} = -8.333 \\times 10^{-3}$ months/(copy/mL).\n\n**Evaluation of $\\frac{\\partial T}{\\partial d}$:**\nUsing the relation $\\frac{\\partial T}{\\partial d} = -\\frac{T}{d}$:\n$$\n\\frac{\\partial T}{\\partial d} = -\\frac{100}{36} = -\\frac{25}{9} \\approx -2.7777...\n$$\nTo four significant figures, $\\frac{\\partial T}{\\partial d} = -2.778$ months/(cell/µL/month).\n\nThe final numerical results, rounded to four significant figures, are:\n-   $T = 100.0$\n-   $\\frac{\\partial T}{\\partial C_{0}} = 0.1667$\n-   $\\frac{\\partial T}{\\partial V_{s}} = -8.333 \\times 10^{-3}$\n-   $\\frac{\\partial T}{\\partial d} = -2.778$\nThese are to be presented in a row matrix.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n100.0 & 0.1667 & -8.333 \\times 10^{-3} & -2.778\n\\end{pmatrix}\n}\n$$", "id": "4652119"}]}